Why This China-Based Education Company Embraces Government Policy
Four Seasons Education is the latest Chinese education company to tap the U.S. market, making its debut on the New York Stock Exchange Wednesday.
While the stock finished the day below its $10 IPO price, chief financial officer and board member Joanne Zuo sees opportunities for growth ahead.
The executive points out that most of the big players in Chinese education each concentrate in different segments so aren't directly competing with one another. Four Seasons, for example, is focused on math. And as a result, Zuo says they're not crowding each other out of the market and predicts more will go public.
“There remains huge room for young companies like us,” she said.
Consulting firm Deloitte recently described the Chinese education market as entering a “golden age.” The company noted that, since 2015, there’s been a stream of social capital invested in the industry, whether through private fundings or mergers and acquisitions.
“Open policies, economic development, and international culture communication has gradually increased the foreign capital flow into China's education industry,” the firm said in a statement.
And the country's tight policies and strict government regulations may actually benefit the company in the long run, says Zuo.
“The government enhances the requirements for compliance, and that will help us to gain more market share from those small players, who don’t really provide good facilities for students,” she said.
Meridith McGraw, White House Reporter at The Wall Street Journal, breaks down Trump’s $200M ballroom plan, D.C. police tensions, and the future of MAGA.
After years of being told that red wine was good for heart health, more Americans appear to be heeding warnings that even moderate alcohol consumption can be unhealthy.
Amazon is now rolling out a service where its Prime members can order their blueberries and milk at the same time as their batteries and other basic items.
Dr. Richard Besser, President & CEO of the Robert Wood Johnson Foundation and former CDC acting director, unpacks the impact of RFK's mRNA funding cuts.
Jessica Inskip, Director of Investor Research at StockBrokers.com and host of MarketMakeHer, unpacks earnings, market outlook, and what history says is next.